Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

The leading global healthcare booking platform DocPlanner has today announced the closing of a €80 million Series E financing round

  • One Peak Partners and Goldman Sachs Private Capital Investing led the round with participation from existing investors Piton Capital and ENERN Investments
  • The new funds will finance continued penetration of core markets, significant hiring plans, product development and potential acquisitions
  • The investment will allow DocPlanner to reinforce its efforts to enhance patient and doctor experiences to achieve the company’s mission ‘to make the healthcare experience more human’
  • This round brings the total raised by DocPlanner to approximately €130 million
  • DocPlanner has surpassed 1,000 employees and is hiring for 100 new positions
The leading global healthcare booking platform DocPlanner has today announced the closing of a €80 million Series E financing round 1
Mariusz Gralewski CEO, docplanner.com

The leading global healthcare booking platform DocPlanner has today announced the closing of a €80 million Series E financing round. This brings the total raised by DocPlanner to approximately €130 million, solidifying its position among the best-funded digital healthcare players globally with operations on 4 continents. One Peak Partners and Goldman Sachs Private Capital Investing are leading the round, with existing investors Piton Capital and ENERN Investments also participating.

DocPlanner is a rapidly growing leading digital healthcare platform offering a suite of marketing and software services to doctors and clinics with the aim of delivering better and more efficient healthcare. The company provides free doctor reviews and booking for patients via its online marketplace. In addition, DocPlanner offers doctors and clinics a SaaS tool used to optimise their patient flow, reduce no-shows, and digitize their practices in order to be able to spend more time with the patient and ultimately improve healthcare outcomes.

Funds will be used in a number of strategic areas. DocPlanner will continue penetrating its core markets in Europe and Latin America with its SaaS-based marketplace offering. The company will continue to pursue R&D to offer innovative software to doctors and clinics. This will involve expansion of its sales, customer success, product development, legal/compliance and marketing teams across geographies. DocPlanner recently surpassed 1,000 employees globally and doesn’t expect to slow down anytime soon, with nearly 100 positions currently open.

Finally, the company may pursue bolt-on acquisitions of young, innovative cloud-based software companies to accelerate growth. Having acquired and successfully integrated competitors in Turkey and Spain (2014 and 2016, respectively), DocPlanner will consider such opportunities going forward to complement its organic growth initiatives.

Mariusz Gralewski, founder and CEO of DocPlanner, said:

“This fresh funding comes at the best moment in the company’s history. The growth rate in our core business is accelerating and we’re seeing more opportunities in our space, both in terms of customer segment and product offering, as the health tech market matures. Since our last funding round, we’ve focused on the core marketplace and SaaS business; now we are making a concentrated push into new growth areas. This is an exciting time for DocPlanner, patients, doctors and partners alike.”

 Humbert de Liedekerke, Managing Partner of One Peak Partners commented:

“We have been very impressed with DocPlanner’s strong growth trajectory, outstanding technology platform and talented management team. We see enormous potential to accelerate the digital transformation of the healthcare industry and look forward to helping DocPlanner further consolidate its position as the world’s largest and most innovative digital healthcare platform.”

Christian Resch, Managing Director at Goldman Sachs Private Capital Investing added:

“DocPlanner has been at the forefront of digital innovation in healthcare for the past seven years. We are impressed by what the business has already achieved for patients, doctors and clinics. We are excited to invest in DocPlanner and work with the company’s strong team on their roadmap to further improve patient and doctor experiences.”